• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Use and utility of C-reactive protein (CRP) in neonatal early-onset sepsis: a secondary analysis of a prospective surveillance study.C反应蛋白(CRP)在新生儿早发型败血症中的应用及效用:一项前瞻性监测研究的二次分析
J Perinatol. 2025 Jan;45(1):139-145. doi: 10.1038/s41372-024-02064-5. Epub 2024 Aug 5.
2
Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.不同的皮质类固醇药物和方案用于加速有早产风险的婴儿的胎儿肺成熟。
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD006764. doi: 10.1002/14651858.CD006764.pub4.
3
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期使用促红细胞生成素预防早产和/或低出生体重儿的红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004863. doi: 10.1002/14651858.CD004863.pub2.
4
***ECD*** maternal C-reactive protein as a predictor of neonatal sepsis.***ECD*** 母血清 C 反应蛋白预测新生儿败血症。
Psychol Health Med. 2024 Jul;29(6):1134-1141. doi: 10.1080/13548506.2022.2029503. Epub 2022 Jan 24.
5
Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.晚期促红细胞生成素预防早产和/或低出生体重儿红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004868. doi: 10.1002/14651858.CD004868.pub2.
6
Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS).住院新生儿和小婴儿脓毒症中抗生素使用模式、病原体和死亡率预测:全球新生儿脓毒症观察队列研究(NeoOBS)。
PLoS Med. 2023 Jun 8;20(6):e1004179. doi: 10.1371/journal.pmed.1004179. eCollection 2023 Jun.
7
Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).足月(37周及以上)胎膜早破时计划早产与期待治疗(等待)的比较。
Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD005302. doi: 10.1002/14651858.CD005302.pub3.
8
Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis.血清C反应蛋白、降钙素原及乳酸脱氢酶用于诊断胰腺坏死。
Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD012645. doi: 10.1002/14651858.CD012645.
9
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
10
Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.对于妊娠37周前胎膜早破的孕妇,计划早产与期待治疗以改善妊娠结局的比较。
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD004735. doi: 10.1002/14651858.CD004735.pub4.

引用本文的文献

1
Bacterial Meningitis in Infants Under 90 Days of Age: A Retrospective Single-Center Study.90日龄以下婴儿的细菌性脑膜炎:一项回顾性单中心研究
Children (Basel). 2024 Nov 22;11(12):1411. doi: 10.3390/children11121411.

本文引用的文献

1
Diagnostic Performance and Patient Outcomes With C-Reactive Protein Use in Early-Onset Sepsis Evaluations.C 反应蛋白在早期脓毒症评估中的诊断性能和患者结局。
J Pediatr. 2023 May;256:98-104.e6. doi: 10.1016/j.jpeds.2022.12.007. Epub 2022 Dec 16.
2
Biomarkers of Neonatal Sepsis: From Being Mere Numbers to Becoming Guiding Diagnostics.新生儿败血症的生物标志物:从单纯的数字到成为指导性诊断指标
Cureus. 2022 Mar 16;14(3):e23215. doi: 10.7759/cureus.23215. eCollection 2022 Mar.
3
A Proposed Framework for the Clinical Management of Neonatal "Culture-Negative" Sepsis.新生儿“培养阴性”败血症临床管理的拟议框架
J Pediatr. 2022 May;244:203-211. doi: 10.1016/j.jpeds.2022.01.006. Epub 2022 Jan 22.
4
Noninfectious influencers of early-onset sepsis biomarkers.非感染性因素对早发性败血症生物标志物的影响。
Pediatr Res. 2022 Jan;91(2):425-431. doi: 10.1038/s41390-021-01861-4. Epub 2021 Nov 20.
5
Antibiotic stewardship in NICU: De-implementing routine CRP to reduce antibiotic usage in neonates at risk for early-onset sepsis.新生儿重症监护病房中的抗生素管理:取消常规 CRP 检测以减少早发性败血症风险新生儿的抗生素使用。
J Perinatol. 2021 Oct;41(10):2488-2494. doi: 10.1038/s41372-021-01110-w. Epub 2021 Jun 8.
6
C-reactive protein in infants with no evidence of early-onset sepsis.无早发性败血症证据的婴儿中的 C 反应蛋白。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):5659-5664. doi: 10.1080/14767058.2021.1888921. Epub 2021 Feb 17.
7
Factors influencing antibiotic duration in culture-negative neonatal early-onset sepsis.影响培养阴性的新生儿早发性败血症抗生素疗程的因素。
Pharmacotherapy. 2021 Feb;41(2):148-161. doi: 10.1002/phar.2507. Epub 2021 Feb 21.
8
C-reactive protein in early-onset neonatal sepsis - a cutoff point for CRP value as a predictor of early-onset neonatal sepsis in term and late preterm infants early after birth?C 反应蛋白在早发型新生儿败血症中的作用 - CRP 值作为预测足月和晚期早产儿出生后早期早发型新生儿败血症的临界点?
J Matern Fetal Neonatal Med. 2022 Dec;35(23):4552-4557. doi: 10.1080/14767058.2020.1856068. Epub 2020 Dec 6.
9
Time to Positivity of Neonatal Blood Cultures for Early-onset Sepsis.新生儿血培养物对早发性败血症的阳性时间。
Pediatr Infect Dis J. 2020 Jul;39(7):634-640. doi: 10.1097/INF.0000000000002632.
10
Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies.2015 至 2017 年早发型新生儿败血症,大肠杆菌的兴起与新型预防策略的需求。
JAMA Pediatr. 2020 Jul 1;174(7):e200593. doi: 10.1001/jamapediatrics.2020.0593. Epub 2020 Jul 6.

C反应蛋白(CRP)在新生儿早发型败血症中的应用及效用:一项前瞻性监测研究的二次分析

Use and utility of C-reactive protein (CRP) in neonatal early-onset sepsis: a secondary analysis of a prospective surveillance study.

作者信息

Kilpatrick Ryan, Greenberg Rachel, Hansen Nellie I, Shankaran Seetha, Carlo Waldemar A, Cotten C Michael, Stoll Barbara J

机构信息

Division of Newborn Medicine, Tufts University School of Medicine, Boston, MA, USA.

Department of Pediatrics, Duke University, Durham, NC, USA.

出版信息

J Perinatol. 2025 Jan;45(1):139-145. doi: 10.1038/s41372-024-02064-5. Epub 2024 Aug 5.

DOI:10.1038/s41372-024-02064-5
PMID:39103472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11711002/
Abstract

OBJECTIVE

Characterize C-reactive protein (CRP) within 72 postnatal hours in early-onset sepsis (EOS).

STUDY DESIGN

Secondary analysis of a prospective surveillance study of neonates with EOS 2015-2017. We examined CRP use by center and neonatal characteristics, and CRP levels by time, neonatal characteristics, clinical signs, and pathogen.

RESULTS

CRP was obtained for 96/235 neonates with EOS, which varied by center (p < 0.001). 71/95 had CRP > 10 mg/L (1 missing). Neonatal characteristics with and without CRP did not differ. There was no relationship between CRP level and timing (p = 0.41) or neonate characteristics. Median CRP was higher with ≥5 vs <5 clinical signs (56, 23 mg/L; p = 0.002), and was not different in Gram-positive vs Gram-negative sepsis (43, 51 mg/L; p = 0.37) or preterm neonates who died vs survived (38, 28 mg/L; p = 0.37).

CONCLUSIONS

Among neonates with EOS, CRP use varied by center. CRP levels did not differ by time, neonate characteristics, pathogen, or death.

CLINICAL TRIALS REGISTRATION

ClinicalTrials.gov ID Early-Onset Sepsis an NICHD/CDC Surveillance Study (EOSII): NCT02410486.

摘要

目的

对早发型败血症(EOS)出生后72小时内的C反应蛋白(CRP)进行特征分析。

研究设计

对2015 - 2017年患有EOS的新生儿进行前瞻性监测研究的二次分析。我们按中心和新生儿特征检查了CRP的使用情况,并按时间、新生儿特征、临床体征和病原体检查了CRP水平。

结果

96/235例患有EOS的新生儿检测了CRP,各中心之间存在差异(p < 0.001)。95例中有71例CRP > 10mg/L(1例数据缺失)。检测和未检测CRP的新生儿特征无差异。CRP水平与检测时间(p = 0.41)或新生儿特征之间无关联。临床体征≥5项与<5项的患儿,CRP中位数更高(56、23mg/L;p = 0.002),革兰氏阳性菌与革兰氏阴性菌败血症患儿的CRP水平无差异(43、51mg/L;p = 0.37),早产死亡与存活患儿的CRP水平也无差异(38、28mg/L;p = 0.37)。

结论

在患有EOS的新生儿中,CRP的使用因中心而异。CRP水平在时间、新生儿特征、病原体或死亡情况方面无差异。

临床试验注册

ClinicalTrials.gov标识符 早发型败血症一项NICHD/CDC监测研究(EOSII):NCT02410486